Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study

医学 内科学 回顾性队列研究 队列 危险系数 倾向得分匹配 严重急性呼吸综合征冠状病毒2型(SARS-CoV-2) 胃肠病学 2019年冠状病毒病(COVID-19) 疾病 置信区间 传染病(医学专业)
作者
Xiangru Xu,Hongze Wu,Guoqiang Jin,Jihan Huang,Jinhua Li,Jing Zhou,Min Cao,Ding Sun,Wen Zhang,Wei Peng,Yuting Pu,Caiyu Chen,Yuting Sun,Hongqiang Yang,Shuang Zhou,Bangjiang Fang
出处
期刊:Phytomedicine [Elsevier BV]
卷期号:111: 154665-154665 被引量:9
标识
DOI:10.1016/j.phymed.2023.154665
摘要

Lianhua Qingwen Granules or Capsules (LHQW) has accumulated much research evidence in the fight against the coronavirus disease 2019 (COVID-19) epidemic. However, there are still few data on its efficacy and safety in children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.To evaluate the efficacy and safety of LHQW in children with SARS-CoV-2 Omicron infection.We conducted a single-center, propensity-score matched retrospective cohort study of children with SARS-CoV-2 Omicron infection in Shanghai New International Expo Center mobile cabin hospital between April 1st and June 1st, 2022. Eligible patients received either LHQW granules/capsules plus supportive care (LHQW group) or supportive care alone (control group). The primary outcome was the negative conversion time of nucleic acid. Secondary outcomes included the negative conversion rate of nucleic acid, the length of hospital stay, clinical disease progression, and cycle threshold [Ct] values for SARS-CoV-2 open reading frame [ORF1ab] or nucleocapsid [N] genes.Overall, 2808 patients were enrolled, and 346 patients in each group were included in the analysis. Among the propensity-score matched groups, LHQW treatment was associated with an accelerated negative conversion time of nucleic acid (median: 5 d vs. 6 d, Hazard ratio: 1.25, 95% CI: 1.08 - 1.46, Log-rank p < 0.001), a higher negative conversion rate of nucleic acid (Day 2 - 6: 2.9% vs. 0.6%, p = 0.036; 29.8% vs. 5.5%, p < 0.001; 42.5% vs. 24.3%, p < 0.001; 51.4% vs. 31.5%, p < 0.001; 63.3% vs. 55.2%, p = 0.030), shorter hospital stay (median: 10 d vs. 11 d, Hazard ratio: 1.50, 95% CI: 1.29 - 1.74, Log-rank p < 0.001), and lower rates of asymptomatic infection progressing to mild (37.9% vs. 46.5%, p = 0.021).Our study suggested that LHQW treatment was associated with faster clinical recovery in children with SARS-CoV-2 Omicron infection.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
牟慕完成签到,获得积分10
刚刚
夜休2024发布了新的文献求助10
刚刚
wangfeng007发布了新的文献求助10
刚刚
Dimples发布了新的文献求助10
刚刚
打打的应助被与月同行采纳,获得10
刚刚
去普渡众生才会更惆怅完成签到,获得积分20
刚刚
ttz关注了科研通微信公众号
刚刚
NexusExplorer的应助被落后满天采纳,获得10
1秒前
无花果的应助被zw采纳,获得10
1秒前
曾图图发布了新的文献求助10
1秒前
雷安完成签到,获得积分10
1秒前
1秒前
周游普列国完成签到 ,获得积分10
1秒前
1秒前
1秒前
sikh发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
2秒前
wangyumumu完成签到,获得积分0
2秒前
3秒前
3秒前
给祖国添麻烦了完成签到,获得积分10
3秒前
3秒前
3秒前
myLv98完成签到,获得积分10
3秒前
3秒前
3秒前
少不入川发布了新的文献求助10
3秒前
Lia完成签到 ,获得积分10
4秒前
聪明威完成签到,获得积分10
4秒前
段鑫盛发布了新的文献求助10
5秒前
JIAFU完成签到 ,获得积分10
5秒前
电池小白完成签到,获得积分10
5秒前
6秒前
Chenzr发布了新的文献求助10
6秒前
6秒前
精明连虎发布了新的文献求助10
6秒前
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8167861
求助须知:如何正确求助?哪些是违规求助? 9560824
关于积分的说明 21757886
捐赠科研通 7759010
什么是DOI,文献DOI怎么找? 3429723
关于科研通互助平台的介绍 2553707
邀请新用户注册赠送积分活动 2474336